Phathom Pharmaceuticals, Inc. PHAT Other operating expenses
Other operating expenses at other companies
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s other operating expenses?
- Phathom Pharmaceuticals, Inc. (PHAT) reported other operating expenses of $61.78M in Q1 2026.
- How has Phathom Pharmaceuticals, Inc.'s other operating expenses changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s other operating expenses decreased by 40.4% year-over-year, from $103.66M to $61.78M.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s other operating expenses?
- Over 4 years (2021 to 2025), Phathom Pharmaceuticals, Inc.'s other operating expenses has grown at a 23.3% compound annual growth rate (CAGR), from $135.08M to $312.5M.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.